Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Vaginal microbiome of reproductive-age women
2010 Standout
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Cancer statistics, 2022
2022 Standout
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Head and neck squamous cell carcinoma
2020 Standout
Cancer statistics, 2020
2020 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study
2004
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
2010
Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies
2007
Expanding global access to radiotherapy
2015 Standout
Human papillomavirus and cervical cancer
2013
Six‐month natural history of oral versus cervical human papillomavirus infection
2007
Inflammation and cancer
2002 StandoutNature
The epidemiology of human papillomavirus infections
2005
Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies
2005
Interaction of human papillomaviruses with the host immune system: A well evolved relationship
2008
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Global Cancer Statistics, 2002
2005 Standout
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers
2016
Family history as a co‐factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: Results from two studies conducted in Costa Rica and the United States
2005
A Population‐Based Study of Vaginal Human Papillomavirus Infection in Hysterectomized Women
2004
Cervical cancer and use of hormonal contraceptives: a systematic review
2003
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Prevalence of HPV Infection Among Females in the United States
2007 Standout
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
2005
The burden of non-communicable diseases in South Africa
2009 Standout
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
2013
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Chapter 5: Updating the natural history of HPV and anogenital cancer
2006
Inflammation and cancer: How hot is the link?
2006
The lower genital tract microbiota in relation to cytokine‐, SLPI‐ and endotoxin levels: application of checkerboard DNA‐DNA hybridization (CDH)
2008
The immune contexture in cancer prognosis and treatment
2017 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
2015
Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer
2011
Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004
2009
Lack of Association of Alcohol and Tobacco with HPV16-Associated Head and Neck Cancer
2007
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Effects of Bacterial Vaginosis and Other Genital Infections on the Natural History of Human Papillomavirus Infection in HIV‐1–Infected and High‐Risk HIV‐1–Uninfected Women
2005
Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States
2003
The known unknowns of HPV natural history
2011
The Expanded Use of HPV Testing in Gynecologic Practice per ASCCP-Guided Management Requires the Use of Well-Validated Assays
2007
A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica
2005
The causal relation between human papillomavirus and cervical cancer
2002 Standout
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
2012
Human papillomavirus and cervical cancer
2007 Standout
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual Life
2007
Environmental co-factors in HPV carcinogenesis
2002
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
2015
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
2011 Standout
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
2011 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Seroprevalence of 8 Oncogenic Human Papillomavirus Genotypes and Acquired Immunity Against Reinfection
2014
Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention
2006
Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study
2003 Standout
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
2012
Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies
2006
Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study
2013
From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas
2015
The molecular landscape of head and neck cancer
2018 Standout
Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population‐based studies
2012
The predicted impact of vaccination on human papillomavirus infections in Australia
2008
Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting
2005
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
2008
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Cervical cancer
2019 Standout
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
External Genital Warts: Diagnosis, Treatment, and Prevention
2002
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
2010
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
The role of the microbiota in inflammation, carcinogenesis, and cancer therapy
2014
Actinomyces and Related Organisms in Human Infections
2015 Standout
Cancer statistics in China, 2015
2016 Standout
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
2013 Standout
Worldwide burden of cancer attributable to HPV by site, country and HPV type
2017 Standout
Human Papillomavirus Infection in Ulaanbaatar, Mongolia: A Population-Based Study
2008
Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
2007
Human Papillomavirus and Cervical Cancer
2003 Standout
Smokers at Higher Risk for Undetected Antibody for Oncogenic Human Papillomavirus Type 16 Infection
2006
Chimeric Antigen Receptor Therapy
2018 Standout
Chapter 3: Cofactors in Human Papillomavirus Carcinogenesis--Role of Parity, Oral Contraceptives, and Tobacco Smoking
2003
Precursors in Cancer Epidemiology: Aligning Definition and Function
2013
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
2014
Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students
2005
Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting
2013
Works of M Alfaro being referenced
HPV DNA Testing in Cervical Cancer Screening: Results from Women in a High‐Risk Province of Costa Rica
2001
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica
2001
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
2003
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
2010
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
2009
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica
2004
Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
1999
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
2001